ישראל - עברית - Ministry of Health

unipharm ltd, israel - sacubitril/valsartan as sodium salt complex as sodium salt complex - sacubitril/valsartan as sodium salt complex as sodium salt complex 49/51 mg - valsartan and sacubitril

ישראל - עברית - Ministry of Health

unipharm ltd, israel - sacubitril/valsartan as sodium salt complex as sodium salt complex - טבליות מצופות - sacubitril/valsartan as sodium salt complex as sodium salt complex 97/103 mg - valsartan and sacubitril

ישראל - עברית - Ministry of Health

unipharm ltd, israel - sacubitril/valsartan as sodium salt complex as sodium salt complex - טבליות מצופות - sacubitril/valsartan as sodium salt complex as sodium salt complex 24/26 mg - valsartan and sacubitril

ישראל - עברית - Ministry of Health

unipharm ltd, israel - valsartan - טבליה - valsartan 160 mg - valsartan

ישראל - עברית - Ministry of Health

unipharm ltd, israel - valsartan - טבליה - valsartan 80 mg - valsartan

ישראל - עברית - Ministry of Health

unipharm ltd, israel - valsartan - טבליה - valsartan 80 mg - valsartan

ישראל - עברית - Ministry of Health

a.l. medi-market ltd. - valsartan - טבליות מצופות פילם - valsartan 160 mg - valsartan

ישראל - עברית - Ministry of Health

a.l. medi-market ltd. - valsartan - טבליות מצופות פילם - valsartan 80 mg - valsartan

ישראל - עברית - Ministry of Health

unipharm ltd, israel - candesartan cilexetil; hydrochlorothiazide - טבליה - hydrochlorothiazide 12.5 mg; candesartan cilexetil 16 mg - candesartan

ישראל - עברית - Ministry of Health

unipharm ltd - valsartan 40 mg - film coated tablets - valsartan - valsartan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan significantly reduced hospitalizations for heart failure. there is no evidence that valsartan provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.